Evolution of the Average Target: PYC Therapeutics Limited

Evolution of the Target Price: PYC Therapeutics Limited

Changes in Analyst Recommendations: PYC Therapeutics Limited

314d518e.h3t6PpIsocTViccpRyF8WdNOrh0eHYGKvowgbXCO750.7D8td6ZE7fav57FePVE-HecZ5yRyUbe-7stGJF3XqPjyDQ5OymTWrbjj_w~d73bcc97e3aad0e5db299c476299378c

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+125.54%
+23.65%
+9.39%
+27.54%
+11.51%
+44.52%
-5.11%
+19.91%
+8.58%
+9.68%
Average +27.52%
Weighted average by Cap. +19.28%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.660AUD
Average target price
3.744AUD
Spread / Average Target
+125.54%
High Price Target
5.000AUD
Spread / Highest target
+201.20%
Low Price Target
2.300AUD
Spread / Lowest Target
+38.55%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.660AUD
Average target price
3.744AUD
Spread / Average Target
+125.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PYC Stock
  4. Consensus PYC Therapeutics Limited